LCI Share Price

Open 20.80 Change Price %
High 22.00 1 Day 0.35 1.68
Low 20.80 1 Week 0.15 0.71
Close 21.20 1 Month -1.70 -7.42
Volume 535203 1 Year 2.89 15.78
52 Week High 39.99
52 Week Low 16.75
LCI Important Levels
Resistance 2 22.31
Resistance 1 21.85
Pivot 21.33
Support 1 20.55
Support 2 20.09
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
VSR 1.95 24.20%
VSR 1.95 24.20%
PBTH 8.23 0.37%
NGD 2.95 1.03%
NGD 2.95 1.03%
GST 1.28 -5.19%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
VSR 1.95 24.20%
VSR 1.95 24.20%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
CHGS 0.01 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
More..

Lannett Co Inc (AMEX: LCI)

LCI Technical Analysis 3
As on 23rd Mar 2017 LCI Share Price closed @ 21.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 24.49 & Sell for SHORT-TERM with Stoploss of 21.24 we also expect STOCK to react on Following IMPORTANT LEVELS.
LCI Target for March
1st Target up-side 24.48
2nd Target up-side 26.22
3rd Target up-side 27.96
1st Target down-side 19.52
2nd Target down-side 17.78
3rd Target down-side 16.04
LCI Other Details
Segment EQ
Market Capital 117666264.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.lannett.com
LCI Address
LCI
9000 State Road
Philadelphia, PA 19136
United States
Phone: 215-333-9000
LCI Latest News
Why Investors remained confident on Lannett Company, Inc. (LCI), Inotek ...   StockNewsJournal   - 22nd Mar 17
Lannett To Participate At Four Upcoming Investor Conferences   PR Newswire (press release)   - 27th Feb 17
Lannett Announces Addition To Management Team   PR Newswire (press release)   - 23rd Feb 17
Lannett Provides Further Update On Methylphenidate ER Tablets   PR Newswire (press release)   - 22nd Feb 17
Lannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility   PR Newswire (press release)   - 23rd Jan 17
Why Lannett Company, Inc. Shares Got Pummeled Today   Motley Fool   - 18th Oct 16
Why Lannett Company, Inc. Jumped Higher Today   Motley Fool   - 24th Aug 16
Lannett Company, Inc. Stock Gained 25.2% Last Month: Here's Why   Motley Fool   - 07th Aug 16
Resurgence Of Lannett: A Growing Opportunity   Seeking Alpha   - 30th Jul 16
3 Biggest Challenges Facing Lannett Company Inc. Stock   Motley Fool   - 20th Apr 16
Interactive Technical Analysis Chart Lannett Co Inc ( LCI AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lannett Co Inc
LCI Business Profile
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company provides its products for various medical indications comprising glaucoma, migraine, antibiotic, anesthetic, endometriosis, irritable bowel syndrome, obesity, congestive heart failure, antipsychotic, pain management, thyroid deficiency, dryness of the mouth, epilepsy, gout, bronchospasms, hypertension, and gallstone. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Fiorinal w/ Codeine #3, Cleocin, Danocrine, Bentyl, Tenuate, Dospan, Lanoxin, Adoxa, Periostat, Prolixin, Dilaudid, Levoxyl, Synthroid, Loxitane, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Dyazide, and Actigall brands. It also manufactures active pharmaceutical ingredients. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. It has development and supply agreements with Azad Pharma AG, Swiss Caps of Switzerland, Pharma 2B, and the GC Group of Israel, as well as with Jerome Stevens Pharmaceuticals, Inc., Cerovene, and Summit Bioscience LLC. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.